Skip to main content

Table 2 False-positive cases characteristics, pathology of index tumors, and additional primary malignancies, diagnostic procedures, and outcomes

From: Detection of additional primary malignant tumor in cancer survivors: the use of PET/CT for image-guided biopsy

 

Age

Sex

1 site

Path

Diagnosis

Outcome

Interval

2

Path

Diagnosis

Outcome

22

55

M

Liver

HCC

FNAC

RFA

0

GB

Cholecystitis

FU/US

Medical TTT

23

35

F

Breast

Invasive ductal carcinoma

FNAC

Lumpectomy/chemotherapy

0

Lung

Post pneumonic nodule

Biopsy

FU

24

32

F

Breast

Invasive ductal carcinoma

FNAC

Mastectomy/chemo-radio

6M

Colon

Colitis

Endoscopy

Medical TTT

25

28

F

Colon

Infiltrating adenocarcinoma

Endoscopy

Colostomy/chemotherapy

0

Breast

Fibroadenoma

Excision

lumpectomy

26

32

F

Breast

Invasive ductal carcinoma

FNAC

Lumpectomy/chemo-radio

0

Thyroid

Thyroiditis

FNAC

Medical TTT

27

60

M

Colon

Adenocarcinoma

Endoscopy

Colostomy/

chemotherapy

9M

adrenal

Metachronous

Metastasis

FNAC

chemotherapy

28

60

F

Lymphoma

NHL(LBC)

LN. excision

Chemotherapy

0

Parotid

Pleo-morphic adenoma

FNAC

Excision

29

45

M

Lymphoma

NHL(LBC)

Tissue biopsy

Chemotherapy

0

Colon

Colitis

Endoscopy

Medical TTT

30

54

F

Lymphoma

NHL(LBC)

Tissue biopsy

Chemotherapy

1 year

Breast

Fibroadenoma

FNAC

Excision